RaySearch Laboratories AB (publ)
Research RaySearch Laboratories AB (publ) (RAY-B) on Bullrun: market cap SEK 5.40B, P/E 29.0, dividend yield 2.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRAY-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryHealth Information Services
- CurrencySEK
- Market capSEK 5.40B
- P/E29.0
- Dividend yield2.2%
- Financial periodQ1 2026
- RevenueSEK 290.30M
- Net incomeSEK 53.20M
- Free cash flowSEK 49.50M
- Gross margin91.9%
Valuation Snapshot
latest market cap is SEK 5.40B; P/E is 29.0; dividend yield is 2.2%.
Peer valuation comparison
Latest P/E is 29.04x versus a Healthcare sector median of 24.46x (18.7% above).
Latest dividend yield is 2.16% versus a Healthcare sector median of 2.11% (2.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 1.34B | SEK 227.77M | SEK 150.80M | 92.4% | 6.65 | SEK 407.30M | SEK 394.80M | SEK 985.30M |
| FY2024 | SEK 1.19B | SEK 203.51M | SEK 471.97M | 91.7% | 5.94 | SEK 462.74M | SEK 472.00M | SEK 876.71M |
| FY2023 | SEK 1.02B | SEK 81.57M | SEK 431.64M | 89.6% | 2.38 | SEK 343.68M | n/a | SEK 735.23M |
| FY2022 | SEK 843.65M | SEK 23.78M | SEK 307.26M | 88.7% | 0.69 | SEK 160.27M | n/a | SEK 657.16M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 5.40B | 29.0 | 2.2% | 4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 4 SEK, yield 2.2%.
| Year | Dividends/share |
|---|---|
| FY2024 | 2 SEK |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is RaySearch Laboratories AB (publ)'s market cap?
RaySearch Laboratories AB (publ)'s market capitalization is SEK 5.40B.
What is RaySearch Laboratories AB (publ)'s P/E ratio?
RaySearch Laboratories AB (publ)'s price-to-earnings (P/E) ratio is 29.0.
Does RaySearch Laboratories AB (publ) pay a dividend?
RaySearch Laboratories AB (publ) has a dividend yield of 2.2%.
What does RaySearch Laboratories AB (publ) do?
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems.